StreetAlpha.app
Home › Stocks › MDWD

MediWound Ltd. (MDWD)

$13.59
▲ +0.37%
LAST CLOSE · NOV 20

MediWound develops enzyme-based therapies that remove damaged tissue from burns and chronic wounds. It last closed at $13.59 on Nov 20, up 0.37% on the day. Over the last 12 months MDWD insiders bought $143K of stock on the open market and sold $82K, according to SEC Form 4 filings.

AI Auto Pilots
Is MDWD in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MDWD.

Key Stats

Last 12 months
Results
Revenue
$17.0M
−16.1% vs a year ago
Net income
−$23.9M
−140.8% margin
Free cash flow
−$21.6M
−127.5% margin
Gross margin
19.2%
$3.3M gross profit
Balance sheet
Cash & equivalents
$4.8M
At Dec 31
Shareholder equity
$43.6M
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $23.8M$23.8MFY2021FY2022: $26.5M$26.5MFY2022FY2023: $18.7M$18.7MFY2023FY2024: $20.2M$20.2MFY2024FY2025: $17.0M$17.0MFY2025

From MDWD's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 5). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on file yet
Reported EPS
—
Quarter ended Jun 2025
Year ago EPS
—
Same quarter last year
Revenue
$5.7M
+12.7% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Not enough quarters on file yet.
Revenue by quarter
Jun 2018: $1.0MJun '18Jun 2019: $20.7MJun '19Jun 2020: $4.0MJun '20Jun 2021: $6.1MJun '21Jun 2022: $4.7MJun '22Jun 2023: $4.8MJun '23Jun 2024: $5.1MJun '24Jun 2025: $5.7MJun '25Latest $5.7M
StreetAlpha's call on MDWDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on MDWD
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on MDWD

Technical Analysis

MDWD · as of the Nov 20 close · updated each morning
Bounce inside a longer downtrend

The stock is 1% above its 20 day and 3% above its 50 day average. It is 10% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 53). The nearest support is the 100 day average at $13.55, and the nearest resistance the Pivot R1 at $13.69.

Short trendBullish
Long trendBearish
MomentumFading
StretchNormal
VolatilityHigh, 4.6%/day
Key levels
$19.7052 week high+45.0%
$14.94200 day average+9.9%
$13.99Swing high (Oct 29)+2.9%
$13.69Pivot R1+0.7%
$13.59Last close
$13.55100 day average−0.3%
$13.54Swing low (Jun 2)−0.4%
$13.52Pivot−0.5%
$13.4920 day average−0.7%
$13.43Pivot S1−1.2%
$13.2150 day average−2.8%
$11.8052 week low−13.2%
Indicators
RSI (14)52.79Middle of its rangeNeutral
MACD0.15Below its signal lineBearish
Stochastic51.6Middle of its rangeNeutral
ADX (14)16.4No clear trend
Williams %R-47.9Oversold below −80, overbought above −20Neutral
CCI (20)12.7Oversold below −100, overbought above 100Neutral
Rate of change−4.6%Change over 10 sessionsBearish
ATR (14)$0.62Typical daily range, 4.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Below
What happened before, for MDWD

What happened before

See how MDWD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow MDWD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How MDWD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for MDWDHow many large options trades hit MDWD, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

MDWD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲42 buying vs 28 selling
  • ▲Shares held by funds +1.7%
  • ▲Funds holding +7
  • ▲Superinvestors: 2 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding8679+8.9%
In funds' top 1021+100.0%
Held by funds–––
New / increased14 / 2814 / 29−2.3%
Reduced / sold out21 / 718 / 100.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See MDWD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

MDWD Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$143K4 buys · 3 insiders
Sold$82K2 sales · 2 insiders
Cluster buy: 3 insiders bought $136K between May 29 and Jun 3.
2026-05 bought $2K2026-06 bought $134K2026-08 sold $75K2026-09 bought $7K2026-09 sold $7KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Sep 1Samuel RubinsteinDirectorBuy525$12.62$7K
Sep 1Samuel RubinsteinDirectorSale525$12.72$7K
Aug 27Shmuel HessCOO & Chief Commercial OfficerSale5,823$12.95$75K
Jun 3Nachum ShamirDirectorBuy6,000$14.00$84K
Jun 1David Morton FoxDirectorBuy3,537$14.11$50K
May 29Samuel RubinsteinDirectorBuy150$14.33$2K
Every insider buy and sale for MDWD over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See MDWD insider trades →

From SEC Form 4 filings by MDWD's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MDWD is in one of them and how their past MDWD trades turned out.

MDWD in the AI portfolios
Loading…

MDWD News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered MDWD in an article yet. Here's the latest on the wider market.

MDWD in the news

About MediWound

MediWound develops enzyme-based therapies that remove damaged tissue from wounds while leaving healthy tissue in place. Its main product, NexoBrid, treats deep burns and is approved in many countries. The company is also developing EscharEx, a topical treatment for chronic wounds such as venous leg ulcers, and a candidate for basal cell carcinoma. It makes its products at its facility in Yavne, Israel, and its customers are hospitals and healthcare providers treating burn and wound patients.

Headquarters
Yavne, Israel